
Ubigene gene knockout cell lines mediated by optimized CRISPR-Cas9 technology provide reliable in vitro models for investigating gene function, signaling pathways, disease mechanisms, and therapeutic targets.
MARCKSL1 (MARCKS like 1) encodes a member of the MARCKS protein family involved in cytoskeletal regulation and protein kinase C and calmodulin signaling. The protein contributes to the organization of cellular structures and affects adherens junction formation. MARCKSL1 is relevant to studies of cytoskeletal dynamics, cell adhesion, and signaling-dependent regulation of cellular architecture.
The 293T cell line is a highly transfectable derivative of the human embryonic kidney (HEK) 293 cell line. Originally designated 293tsA1609neo, it was generated by introducing the SV40 large T-antigen gene and a neomycin resistance gene into an adenovirus-immortalized human embryonic kidney cell subline. The cells express SV40 large T-antigen and support replication of vectors containing the SV40 origin of replication. Due to their high transfection efficiency and favorable properties for gene expression and protein production, 293T cells are widely used for molecular biology studies, recombinant protein expression, and production of viral vectors including retroviral and lentiviral systems.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 2
Reference Transcript: NM_023009
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use







Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?